ResMed expands in EU with new M&A
ResMed (ASX:RMD) has acquired Prague-based medical device distributor Unimedis for an undisclosed sum.
Unimedis distributes sleep-disordered breathing treatment equipment in the Czech Republic and Slovakia.
As part of the acquisition, Unimedis’ Ondrej Kalas will take the role of ResMed’s country manager for the two markets.
ResMed Europe president Anne Reiser said the acquisition will help the company expand the European distribution reach for its own sleep breathing products.
“The Czech and Slovak markets have tremendous growth opportunity for our core business in treating sleep-disordered breathing and for our growing portfolio of respiratory care and cardiology solutions,” she said.
“This acquisition continues ResMed’s emerging market strategy of growing our distribution to bring … sleep-disordered breathing and respiratory-care solutions to places where they’re needed most.”
The new European expansion builds on the October purchase of Warsaw-based Mediserv, which has now been rebranded as ResMed Poland.
ResMed (ASX:RMD) shares were trading 1.12% higher at $5.41 as of around 1 pm on Tuesday.
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
RNA-targeted therapy shows promise for childhood dementia
Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...
